Grantham, Mayo, Van Otterloo & Co (GMO)
NOV icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s NOV NOV Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NOV Stock Details NOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4M Sell
215,380
-807
-0.4% -$16.1K 0.01% 354
2026
Q1 		$4.07M Buy
+216,187
New +$4.06M 0.01% 352
2017
Q3 		– Sell
-13,290
Closed -$438K – 607
2017
Q2 		$438K Sell
13,290
-20,510
-61% -$708K ﹤0.01% 424
2017
Q1 		$1.35M Buy
33,800
+400
+1% +$15.6K 0.01% 346
2016
Q4 		$1.25M Sell
33,400
-1,400
-4% -$51K 0.01% 354
2016
Q3 		$1.28M Buy
34,800
+2,500
+8% +$84K 0.01% 349
2016
Q2 		$1.09M Buy
32,300
+7,087
+28% +$228K ﹤0.01% 409
2016
Q1 		$784K Buy
25,213
+18,300
+265% +$559K ﹤0.01% 436
2015
Q4 		$232K Sell
6,913
-24,300
-78% -$903K ﹤0.01% 511
2015
Q3 		$1.18M Buy
31,213
+25,489
+445% +$1.04M ﹤0.01% 393
2015
Q2 		$276K Buy
5,724
+860
+18% +$44.2K ﹤0.01% 416
2015
Q1 		$243K Buy
4,864
+900
+23% +$48.8K ﹤0.01% 415
2014
Q4 		$260K Sell
3,964
-68,005
-94% -$4.74M ﹤0.01% 417
2014
Q3 		$5.48M Sell
71,969
-800
-1% -$66.1K 0.01% 261
2014
Q2 		$5.99M Sell
72,769
-43,676
-38% -$3.25M 0.02% 242
2014
Q1 		$8.18M Buy
116,445
+8,983
+8% +$616K 0.02% 226
2013
Q4 		$7.71M Sell
107,462
-8,539
-7% -$621K 0.02% 241
2013
Q3 		$8.17M Buy
116,001
+23,067
+25% +$1.54M 0.02% 234
2013
Q2 		$5.77M Buy
+92,934
New +$5.73M 0.02% 280

Other funds holding NOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NOV Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its NOV (NOV) stake by 0.37% in Q2 2026, selling an estimated $16.1K and leaving 215,380 shares worth $4M. The position accounts for 0.01% of the portfolio, ranked #354.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NOV in Q2 2013 and has held it in 19 quarters since. The position peaked at $8.18M in Q1 2014. 488 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 215,380 shares of NOV worth $4M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 807 NOV shares in Q2 2026, an estimated $16.1K.
  • NOV made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #354 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NOV in Q2 2013 and has held it in 19 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s NOV position peaked at $8.18M in Q1 2014.
  • 488 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.